An inhibitor of PDE2 and PDE3
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Carbazeran

Item No. 26092

Technical Information
Formal Name
N-ethyl-carbamic acid, 1-(6,7-dimethoxy-1-phthalazinyl)-4-piperidinyl ester
CAS Number
70724-25-3
Molecular Formula
C18H24N4O4
Formula Weight
Purity
≥95%
Formulation
A solid
Chloroform: Slightly SolubleMethanol: Slightly Soluble
SMILES
COC1=C(OC)C=C(C=NN=C2N3CCC(OC(NCC)=O)CC3)C2=C1
InChi Code
InChI=1S/C18H24N4O4/c1-4-19-18(23)26-13-5-7-22(8-6-13)17-14-10-16(25-3)15(24-2)9-12(14)11-20-21-17/h9-11,13H,4-8H2,1-3H3,(H,19,23)
InChi Key
QJGVXJYGDBSPSJ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Carbazeran is an inhibitor of phosphodiesterase 2 (PDE2) and PDE3.1 It inhibits cAMP hydrolysis (IC50 = 4.1 µM in rabbit heart ventricles) selectively over cGMP hydrolysis (IC50 = 171 µM).2 It induces positive inotropic (EC50 = 100 µM) and negative chronotropic effects in isolated rabbit papillary muscle and right atria, respectively. Carbazeran is also a substrate for the enzyme aldehyde oxidase (AOX1), which is involved in the metabolism of xenobiotics.3,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Price, B., Pyne, N.J., and Houslay, M.D. Proteolysis of cyclic AMP phosphodiesterase-II attenuates its ability to be inhibited by compounds which exert positive inotropic actions in cardiac tissue. Biochem. Pharmacol. 36(23), 4047-4054 (1987).

    2. Shahid, M., and Rodger, I.W. Chronotropic and inotropic actions of amrinone, carbazeran and isobutylmethyl xanthine: Role of phosphodiesterase inhibition. Br. J. Pharmacol. 98(1), 291-301 (1989).

    3. Hutzler, J.M., Yang, Y.S., Albaugh, D., et alCharacterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes. Drug Metab. Dispos. 40(2), 267-275 (2012).

    4. Wilkinson, D.J., Southall, R.L., Li, M., et alMinipig and human metabolism of aldehyde oxidase substrates: In Vitro-in Vivo comparisons. AAPS J. 19(4), 1163-1174 (2017).